The group of M+ tumours showing three or more abnormal genes was characterised by a single genetic mutation (usually K-Ras; 53%) and by two epigenetic alterations (equally affecting p16INK4A, RASSF1A and E-Cadherin). The gene discussed is CDKN2A; the disease is neoplasm.